These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17889555)

  • 1. A summary of the workshop on passive immunization using monoclonal antibodies for HIV/AIDS, held at the National Institute of Allergy and Infectious Diseases, Bethesda, 10 March 2006.
    Bansal GP
    Biologicals; 2007 Oct; 35(4):367-71. PubMed ID: 17889555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies against HIV -- back in the major leagues?
    Ferrantelli F; Ruprecht RM
    Curr Opin Immunol; 2002 Aug; 14(4):495-502. PubMed ID: 12088685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprophylaxis against mother-to-child transmission of HIV-1.
    Gorny MK; Zolla-Pazner S
    PLoS Med; 2006 Jul; 3(7):e259. PubMed ID: 16842019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive immunization to prevent mother-infant transmission of human immunodeficiency virus: current issues and future directions.
    Mofenson LM; Burns DN
    Pediatr Infect Dis J; 1991 Jun; 10(6):456-62. PubMed ID: 1712936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunization for the treatment and prevention of HIV infection.
    Karwowska S; Zolla-Pazner S
    Biotechnol Ther; 1991; 2(1-2):31-48. PubMed ID: 1845123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive immunization for the treatment of HIV infection.
    Jacobson JM
    Mt Sinai J Med; 1998 Jan; 65(1):22-6. PubMed ID: 9458680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive immunization for the prevention and treatment of HIV infection.
    Zolla-Pazner S; Gorny MK
    AIDS; 1992 Nov; 6(11):1235-47. PubMed ID: 1472330
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.
    Anderson DJ; Politch JA; Zeitlin L; Hiatt A; Kadasia K; Mayer KH; Ruprecht RM; Villinger F; Whaley KJ
    AIDS; 2017 Jul; 31(11):1505-1517. PubMed ID: 28463876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal antibodies for passive immunotherapy of HIV-1.
    Katinger H
    Antibiot Chemother (1971); 1994; 46():25-37. PubMed ID: 7826037
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventive and therapeutic features of broadly neutralising monoclonal antibodies against HIV-1.
    Jaworski JP; Cahn P
    Lancet HIV; 2018 Dec; 5(12):e723-e731. PubMed ID: 30245003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity in HIV infection and implications for vaccine design: a summary of the workshop held at the National Institute of Allergy and Infectious Diseases, Bethesda on February 25-26, 2010.
    Bansal GP; Leitner WW
    Vaccine; 2010 Dec; 28(52):8229-35. PubMed ID: 21073990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group].
    Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R
    Sante; 1997; 7(2):115-25. PubMed ID: 9273118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques.
    Ferrantelli F; Hofmann-Lehmann R; Rasmussen RA; Wang T; Xu W; Li PL; Montefiori DC; Cavacini LA; Katinger H; Stiegler G; Anderson DC; McClure HM; Ruprecht RM
    AIDS; 2003 Feb; 17(3):301-9. PubMed ID: 12556683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mother-infant HIV trial on track.
    Science; 1993 Oct; 262(5131):182. PubMed ID: 8211136
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutralizing antibodies take a swipe at HIV in vivo.
    Montefiori DC
    Nat Med; 2005 Jun; 11(6):593-4. PubMed ID: 15937465
    [No Abstract]   [Full Text] [Related]  

  • 16. Report of the 2014 Cent Gardes HIV Vaccine Conference - Part 1: Neutralizing Antibodies; Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 October 2014.
    Girard MP; Picot V; Longuet C; Nabel GJ
    Vaccine; 2015 Jul; 33(31):3605-8. PubMed ID: 25769208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing HIV infection in infants in developing countries: NIAID's role. National Institute of Allergy and Infectious Diseases.
    NIAID AIDS Agenda; 1997 Nov; ():1-2, 9-10. PubMed ID: 11364919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces.
    Zeitlin L; Palmer C; Whaley KJ
    Biotechnol Genet Eng Rev; 2002; 19():121-38. PubMed ID: 12520875
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunology. Close to the edge: neutralizing the HIV-1 envelope.
    Nabel GJ
    Science; 2005 Jun; 308(5730):1878-9. PubMed ID: 15976295
    [No Abstract]   [Full Text] [Related]  

  • 20. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk.
    Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR
    J Virol; 2017 May; 91(9):. PubMed ID: 28202762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.